Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

748.01 -1.91 (-0.25%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount. 
Via InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology. 
Via InvestorPlace
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for... 
Via Benzinga
Exposures COVID-19
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
Via Benzinga
Nearly 50% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 4 Stocks
The billionaire's family fund is surprisingly concentrated. 
Via The Motley Fool
Why Eli Lilly Stock Is Jumping Today
Investors are cheering the big-pharma company's improved outlook. 
Via The Motley Fool
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
Exposures US Equities
Eli Lilly Just Announced More Good News: Time to Buy?
There's no stopping this high-flying biotech. 
Via The Motley Fool
How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.
We also look at the "treasure hunt" economy. 
Via The Motley Fool
These 3 Companies Recently Lifted Guidance
Several companies have raised their outlooks, with shares moving higher following the announcements. For those interested in recent bullish activity, let’s take a closer look at each. 
Via Talk Markets
Americans Swap $5 Burgers For $1,000 Weight Loss Drugs — Is Soda Getting Left Behind Too?
Weight-loss drugs may be impacting fast-food sales, as Eli Lilly beats estimates and raises revenue guidance while McDonald's and Coca-Cola report underwhelming quarters. 
Via Benzinga
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs
Eli Lilly boosts production for obesity and diabetes drugs, reports mixed Q1 results. Expectations for supply growth in 2024 outlined. Insights into payor access and reimbursement strategies... 
Via Benzinga
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stocks Dive On Fears Of Hawkish Fed; Treasury Yields Rise, Bitcoin Tumbles To $60,000: What's Driving Markets Tuesday?
Investor apprehension grips Wall Street with major indices showing midday losses on Tuesday in New York trading, ahead of the Federal Reserve’s potentially hawkish pivot in Wednesday’s meeting. 
Via Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
FOMC Meeting Samsung Over Takes Apple, AI Demand Indication Ahead From AMD, Amazon And Super Micro
To gain an edge, this is what you need to know today. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
LLY Stock Earnings: Eli Lilly Beats EPS, Misses Revenue for Q1 2024
LLY stock results show that Eli Lilly beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
"Eli Lilly & Co's Q1 2024: Revenue hits $8.8 billion, up 26% Y/Y, driven by volume & higher prices. Strong demand for key drugs like Mounjaro & Verzenio. EPS beats at $2.58. FY24 guidance raised to... 
Via Benzinga
Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily Beat
Overall revenue fell short in Q1. Lilly stock is set to cross a key level. 
Via Investor's Business Daily
Wall Street On Edge Ahead Of Fed Decision, Spotlight Falls On Amazon And AMD Earnings: Analyst Says Stocks Survive 'Fragility Test' As April Ends
U.S. stocks appear to be on the back foot early on Tuesday, with index futures trading modestly lower in early pre-market activity. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Markets Up On Tesla, Q1 Earnings; Q1 Beats After The Bell
Market indices finished in the green across the board this Monday. It’s now the third straight day higher going back to Thursday of last week, and recovered from a quick drop into the red (mostly)... 
Via Talk Markets
Here's How Much Stock Eli Lilly Repurchased in 2023
Hint: It probably wasn't as much as you might imagine given the company's immensity. 
Via The Motley Fool
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report
Eli Lilly investors may be eyeing potential gains from dividends. The company is currently offering an annual dividend yield of 0.71%. 
Via Benzinga
Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now
Many technology stocks are soaring, and you may be wondering if they've gotten too expensive. 
Via The Motley Fool
Is Viking Therapeutics Incredibly Undervalued?
The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound. 
Via The Motley Fool
Forget Nvidia, These Unstoppable Stocks Are Better Buys
These stocks have tremendous potential, and it doesn't depend on the growth prospects for artificial intelligence. 
Via The Motley Fool
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On
Eli Lilly may be on the verge of another breakthrough, thanks to its hit GLP-1 medications. 
Via The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
You'll get dividends and more with these great stocks. 
Via The Motley Fool
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.